AVE 33.3% 0.2¢ avecho biotechnology limited

Fair points, tangent. Your comment re the Asian launch does...

  1. 379 Posts.
    Fair points, tangent. Your comment re the Asian launch does perhaps mitigate my first reaction.

    Still, your last sentence does sum up the heebie jeebies I think quite a number of us have over POH's inhouse run for consumer product glory.

    National launch with one sales/marketing person who, with no disrespect to her, I seem to recall had no more than a middle ranking role on her previous cv. Launch into much bigger market, two people!

    I keep reflecting on jev's comment that they may have been forced into 'Plan B'. Even taking your points, starting to recruit this late does it smack of rather belated arrangements - even hurried improvisation? Are we perhaps even into 'Plan C' - or 'D'?

    Whatever emerges in March re funding, it looks as if the next few months will be nailbiting for shareholders.



 
watchlist Created with Sketch. Add AVE (ASX) to my watchlist
(20min delay)
Last
0.2¢
Change
-0.001(33.3%)
Mkt cap ! $6.339M
Open High Low Value Volume
0.2¢ 0.2¢ 0.2¢ $512 255.8K

Buyers (Bids)

No. Vol. Price($)
57 101300639 0.2¢
 

Sellers (Offers)

Price($) Vol. No.
0.3¢ 21064873 12
View Market Depth
Last trade - 11.16am 28/06/2024 (20 minute delay) ?
AVE (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.